Oral dosing of rats with OM-89 results in the appearance of specific OM- 89 antibodies of the IgG2(2a) isotype: Possible significance in the treatment of rheumatoid arthritis

International Journal of Immunopharmacology

Volumn 19, Issue 9-10, 1997, Pages 569-572

  Phipps, P A ^a   Moore, A R ^a   Gowland, G ^a   Khanam, A ^a   Willoughby, D A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; OM 89;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; IMMUNOGLOBULIN PRODUCTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ESCHERICHIA COLI; HEAT-SHOCK PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; RATS, WISTAR; T-LYMPHOCYTES;

EID: 0031224892     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(97)00053-2     Document Type: Conference Paper

References (28)

1. Bach, F. H., Ferran, C., Hechenleitner, P., Mark, W., Koyamada, N., Miyatake, T., Winkler, H., Badrichani, A., Candinas, D. & Hancock, W. W. (1997) Accommodation of vascularised xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nature Med., 3(2), 196-204.
2. Bessler, W. G., Beck, P., Konetznick, U., Loleit, M., Sedelmeier, E., Hoffmann, P., Strecker, M. & Stocklin, S. (1991) Biological activity of bacterial surface components: immunogenicity and immunomodulatory properties of a bacterial extract from Escherichia coli. Arzneim Forsch./ Drug Res., 41(1), 274-279.
3. Billingham, M. E. J., Careny, S., Butler, R. & Colston, M. J. (1990) A myvobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J. exp. Med., 171, 339-344.
4. Bosch, A., Benedi, V. J., Pares, R. & Jofre, J. (1988) Enhancement of the humoral reponse and resistance to bacterial infection in mice by oral administration of a bacterial immunomodulator (OM-89). Immunopharmacol. Immunotoxicol., 10, 333-343.
5. Bottex, C., Cristaw, B., Corazza, J. L., Mougin, B. & Fontagnes, R. (1988) Effects of two bacterial extracts, OM-89 and Broncho-Vaxom, on IL-1 release and metabolic activity of a human macrophage cell line. Int. J. Immunother., 4, 203-312.
6. Bottex, C., Martin, A. & Fontages, R. (1990) Action of a mycotoxin (Diacetoxyscirpenol) on the immune response of the mouse-interaction with an immunodulator (OM-89). Immunopharmacol. Immunotoxicol., 12, 311-321.
7. Brackertz, D. & Vischer, T. L. (1986) OM-8980 in rheumatoid arthritis: a six month double blind placebo controlled multicentre study. J. Rheumatol., 16, 19-23.
8. DeNagel, D. C. & Pierce, S. K. (1992) A case for chaperones in antigen processing. Immunol. Today, 13(3), 86-89.
9. Farine, J. C. & Farre, A. J. (1988) Comparison of two disease modifying antirheumatic drugs - Auranofin and OM-89 on adjuvant arthritis in the rat. Int. J. Immunopath. Pharm., 1, 39-44.
10. Ferraresso, M., Tian, L., Ghobrial, R., Strepkowski, S. M. & Kahan, B. D. (1994) Rapamycin inhibits production of cytotoxic but not non-cytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J. Immunol., 153, 3307-3318.
11. Fontagnes, R., Burkhart, M. F., Bottex, C. & Farine, J. C. (1988). Immunopharmacological investigation with the orally administered immunostimulant OM-89 in the mouse. In Advances in Immunmodulation (eds. Bizzini, B. and Bonmassar, E.), pp. 139-145. Pythagora Press, Rome.
12. Franchimont, N., Vrinddts-Gevaert, Y., Collette, Y. & Franchimont, P. (1991) Effects of a hydrosoluble bacterial extract of Eschericia coli (OM-89) on cytokine production by peripheral blood mononuclear cells from healthy subjects and patients with rheumatoid arthritis. Scand. J. Rheumatol., 20, 196-203.
13. Hoffmann, M. K. & Kappler, J. W. (1978) Two distinct mechanisms of immune suppression by antibody. Nature, 272, 64-65.
14. Kiesal, U., Farine, J. C. & Kolb, H. (1994) Prevention of diabetes in BB rats by an E. coli extract (OM-89). Int. J. Immunopath. Pharm., 7, 193-199.
15. Kingston, A. E., Hicks, C. A., Colston, M. J. & Billingham, M. E. J. (1996) A 71-kD heat-shock protein (hsp) from M. tuberculosis has modulatory effects on experimental rat arthritis. Clin. exp. Immunol., 103, 77-82.
16. Mouthon, L. (1996) Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin. exp. Immunol., 104(1), 3-9.
17. Pierce, S. K. (1994) Molecular chaperones in the processing and presentation of antigen to helper T cells. Experentia, 50, 1026-1030.
18. Polla, B. S., Baladi, S., Fuller, K. & Rook, G. (1995) Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally induced tolerance? Experentia, 51, 775-779.
19. Sedelmeier, E. A. & Bessler, W. G. (1995) Biological activity of bacterial cell wall components: immunogenicity of the bacterial extract OM-89. Immunopharm., 29, 29-36.
20. Thompson, S. J., Rook, G. A. W., Brealey, R. J., Van der Zee, R. & Elson, C. J. (1990) Autoimmune reactions to heat-shock proteins in pristane induced arthritis. Eur. J. Immunol., 20, 2479-2483.
21. Twisk, A. J., Hoeban-Schornagel, K. & Kraal, G. (1991) OM-89: its effect on T suppressor cell migration and on the develpoment of systemic lupus erythematosus. Int. J. Immunother., 7, 181-187.
22. Van den Broek, M. F., Hogervorst, E. J. M., Van der Bruggen, M. C. J., Van Eden, W., Van der Zee, R. & Van den Berg, W. B. (1989) Protection against streptococcal cell wall induced arthritis by pretreatment with 65 kD mycobacterial heat shock protein. J. exp. Med., 170, 449-466.
23. Van Eden, W., Thole, J. E. R., Van der Zee, R., Noordzij, A., Van Embden, J. D. A., Hensen, E. J. & Cohen, I. R. (1988) Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature, 331, 171-173.
24. Van Pham, T., Kreis, B., Corradin-Betz, S., Bauer, J. & Mauel, J. (1990) Metabolic and functional stimulation of lymphocytes and macrophages by an Eschericia coli extract (OM-89); in vitro studies. J. Biol. Respon. Modifiers, 9, 231-240.
25. Voller, A. & De Savigny, D. (1981). Enzyme linked immunosorbent assay (ELISA). In Techniques in Clinical Immunology (ed. Thompson, R. A.), pp. 160-162. Blackwell Scientific, Oxford.
26. Willis, D., Moore, A. R., Gowland, G. & Willoughby, D. A. (1995) Polyarthritis in the rat; effects of tolerance and sensitisation to the bacterial extract OM-89 with a possible mode of action. Br. J. Rheum., 34, 1135-1138.
27. Willis, D., Moore, A. R., Gowland, G. & Willoughby, D. A. (1995) OM-89 modulation of chronic inflammation: relevance to clinical use. Br. J. Rheum., 34, 525-528.
28. Wybran, J., Libin, M. & Schandene, L. (1989) Enhance ment of cytokine production and natural killer cell activity by an Eschericia coli extract. Onkologie, 3(12), 22-25.